Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells

Journal of Neural Transmission

Volumn 117, Issue 6, 2010, Pages 695-698

  Szende, B ^a   Barna, G ^a   Magyar, Kálmán ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

( ) Deprenyl; Glutathione depletion; l buthionine (S,R) sulfoximine; Melanoma cells; Tissue culture

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; BUTHIONINE SULFOXIMINE; DESPRENYL N OXIDE; GLUTATHIONE; NORSELEGILINE; SELEGILINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL LOSS; CELL PROTECTION; CELL STRAIN A 2058; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; MITOCHONDRIAL MEMBRANE; MITOSIS RATE; PRIORITY JOURNAL;

AMPHETAMINES; BUTHIONINE SULFOXIMINE; CELL DEATH; CELL LINE, TUMOR; CYTOPROTECTION; DRUG INTERACTIONS; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; MELANOMA; MONOAMINE OXIDASE INHIBITORS; RADIATION-SENSITIZING AGENTS; SELEGILINE; SERUM;

EID: 77954543397     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0413-8     Document Type: Article

References (20)

1. MC Carillo K Kitani S Kanai Y Sato K Miyasaka GO Ivy 1994 (-)-Deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male mice Life Sci 54 975 981 10.1016/0024-3205(94)00499-4 (Pubitemid 24110162)
2. J Gong F Traganos Z Darzynkiewicz 1994 A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry Anal Biochem 218 2 314 319 10.1006/abio.1994.1184 1:CAS:528: DyaK2cXivFensrg%3D 8074286 (Pubitemid 24141629)
3. A Jain J Mårtensson E Stole PA Auld A Meister 1991 Glutathione deficiency leads to mitochondrial damage in brain Proc Natl Acad Sci USA 88 5 1913 1917 10.1073/pnas.88.5.1913 1:CAS:528:DyaK3MXhs1aqsbs%3D 2000395
4. K Magyar B Szende 2004 (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties Neurotoxicology 25 1-2 233 242 10.1016/S0161-813X(03)00102-5 1:CAS:528:DC%2BD3sXhtVSjtLvF 14697898 (Pubitemid 38054334)
5. K Magyar M Pálfi T Tábi H Kalász B Szende É Szöko″ 2004 Pharmacological aspects of (-)deprenyl Curr Med Chem 11 2017 2031 1:CAS:528:DC%2BD2cXlslWmu7Y%3D 15279565
6. Magyar K, Szatmáry I, Szebeni G, Lengyel J (2007) Pharmacokinetic studies of (-) deprenyl and some of its metabolites in mouse. J Neural Transm (Suppl 72):165-173
7. J Mårtensson A Jain E Stole W Frayer PA Auld A Meister 1991 Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress Proc Natl Acad Sci USA 88 20 9360 9364 10.1073/pnas.88.20.9360 1681551
8. A Meister 1991 Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy Pharmacol Ther 51 2 155 194 10.1016/0163-7258(91)90076-X 1:CAS:528:DyaK38Xht1Shs7g%3D 1784629
9. C Mytilineou EK Leonardi P Radcliffe EH Heinonen SK Han P Werner G Cohen CW Olanow 1998 Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion J Pharmacol Exp Ther 284 2 700 706 1:CAS:528:DyaK1cXhtFWkt7Y%3D 9454817
10. GP Reynolds JD Elsworth K Blau M Sandler AJ Lees GM Stern 1978 Deprenyl is metabolized to methamphetamine and amphetamine in man Br J Clin Pharmacol 6 6 542 544 1:CAS:528:DyaE1MXpslartQ%3D%3D 728327
11. NA Seniuk JT Henderson WG Tatton JC Roder 1994 Increased CNTF gene expression in process-bearing astrocytes following injury is augmented by R(-)-deprenyl J Neurosci Res 37 2 278 286 10.1002/jnr.490370213 1:CAS:528:DyaK2cXhvVart7k%3D 8060389
12. M Sugiura R Kato 1977 Reduction of tertiary amine N-oxides by rat liver mitochondria J Pharmacol Exp Ther 200 25 32 1:CAS:528:DyaE2sXltF2qtQ%3D%3D 13201
13. B Szende G Bokonyi J Bocsi G Kéri F Tímár K Magyar 2001 Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites J Neural Transm 108 1 25 33 10.1007/s007020170094 1:CAS:528:DC%2BD3MXivVKku7g%3D 11261744 (Pubitemid 32692611)
14. É Szöko″ T Tábi T Borbás B Dalmadi K Tihanyi K Magyar 2004 Assessment of the N-oxidation of deprenyl, methamphetamine, and amphetamine enantiomers by chiral capillary electrophoresis: an in vitro metabolism study Electrophoresis 25 16 2866 2875 10.1002/elps.200406023 15352021 (Pubitemid 39236521)
15. É Szöko″ T Tábi AS Halász M Pálfi H Kalász K Magyar 2004 Chiral characterization and quantification of deprenyl-N-oxide and other deprenyl metabolites in rat urine by capillary electrophoresis Chromatographia Suppl 60 S245 S251
16. WG Tatton RME Chalmers-Redman 1996 Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration Neurology 47 Suppl 3 S171 S183 1:CAS:528:DyaK2sXhtlGmsg%3D%3D 8959986
17. WG Tatton WY Ju DP Holland C Tai M Kwan 1994 (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis J Neurochem 63 4 1572 1575 1:CAS:528:DyaK2cXmt1WrsLg%3D 7931312
18. WG Tatton RM Chalmers-Redman WJ Ju M Mammen GW Carlile AW Pong NA Tatton 2002 Propargylamines induce anti-apoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells J Pharmacol Exp Ther 301 2 753 764 10.1124/jpet.301.2.753 1:CAS:528:DC%2BD38XjtlKisL8%3D 11961082 (Pubitemid 34429993)
19. MBH Youdim M Weinstock 2002 Novel neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline Mech Ageing Dev 123 1081 1086 10.1016/S0047-6374(01)00391-8 1:CAS:528: DC%2BD38XktFOlsbo%3D 12044957 (Pubitemid 34603091)
20. MBH Youdim A Wadia W Tatton M Weinstock 2006 The anti-parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo Ann NY Acad Sci 939 450 458